PRESS RELEASE published on 04/05/2024 at 10:17, 2 years 3 months ago APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast APONTIS PHARMA partners with Novartis for asthma medications distribution and marketing, raising forecast for 2024 financial year Distribution Agreement APONTIS PHARMA Asthma Medications Novartis Forecast Increase
BRIEF published on 04/05/2024 at 10:15, 2 years 3 months ago APONTIS PHARMA AG Enhances Forecast Following Agreement with Novartis APONTIS PHARMA AG Financial Growth Forecast Upgrade Novartis Agreement Asthma Medications
BRIEF published on 04/05/2024 at 10:15, 2 years 3 months ago APONTIS PHARMA AG améliore ses prévisions suite à un accord avec Novartis Croissance Financière APONTIS PHARMA AG Mise À Niveau Des Prévisions Accord Novartis Médicaments Contre L'asthme
PRESS RELEASE published on 04/05/2024 at 10:10, 2 years 3 months ago EQS-Adhoc: APONTIS PHARMA AG raises forecast after entering five-year distribution and marketing agreement with Novartis for two asthma medications APONTIS PHARMA AG raises forecast following agreement with Novartis for asthma medications Forecast Raise Financial Outlook APONTIS PHARMA AG Novartis Agreement Asthma Medications
BRIEF published on 03/28/2024 at 07:35, 2 years 3 months ago APONTIS PHARMA Anticipates Profitable Growth in 2024 After Restructuring APONTIS PHARMA Single Pill Combinations Financial Results 2023 Profitable Growth 2024 Restructuring Program
BRIEF published on 03/28/2024 at 07:35, 2 years 3 months ago APONTIS PHARMA prévoit une croissance rentable en 2024 après sa restructuration Résultats Financiers 2023 PHARMA APONTIS Croissance Rentable 2024 Combinaisons De Pilules Uniques Programme De Restructuration
PRESS RELEASE published on 03/28/2024 at 07:30, 2 years 3 months ago APONTIS PHARMA expects profitable growth again in 2024 APONTIS PHARMA expects profitable growth in 2024 with sales forecasted to rise to EUR 41.7 million and positive EBITDA of EUR 1.8 million. Performance and efficiency improvements drive future growth EBITDA Profitable Growth APONTIS PHARMA Sales Forecast Efficiency Improvements
PRESS RELEASE published on 02/09/2024 at 10:52, 2 years 4 months ago Original-Research: APONTIS PHARMA AG (von Montega AG): Kaufen APONTIS PHARMA AG hat ein Strategie-Update gegeben und finanzielle Details aus der Restrukturierung bekannt gegeben, was zu einer Reduktion der Break Even-Schwelle führt APONTIS PHARMA AG Strategie-Update Restrukturierung Finanzielle Details Break Even-Schwelle
PRESS RELEASE published on 02/06/2024 at 07:30, 2 years 5 months ago APONTIS PHARMA successfully completes performance and efficiency improvement program APONTIS PHARMA successfully completes performance and efficiency improvement program, reducing headcount and expenses. New go-to-market approach for Single Pill combinations to start on 1 March 2024 Pharmaceutical Company Efficiency APONTIS PHARMA Performance Improvement Single Pill Combinations
PRESS RELEASE published on 11/09/2023 at 07:30, 2 years 7 months ago APONTIS PHARMA presents details of the restructuring and efficiency program – Nine-month figures for 2023 and new sales and earnings forecast for 2023 published
Published on 07/07/2026 at 13:00, 9 minutes ago Prospect Ridge Awarded Excalibur Drill Permit - Maiden Drill Program Planned For July 2026
Published on 07/07/2026 at 12:30, 39 minutes ago Trans Canada Gold Has Commenced Drilling at the Harrison Lake District Scale Gold Project
Published on 07/07/2026 at 12:00, 1 hour 9 minutes ago Lobe Sciences Files Management Information Circular for Annual General and Special Meeting on July 30, 2026
Published on 07/07/2026 at 12:00, 1 hour 9 minutes ago Banyan Gold Advances AurMac Toward a PEA with Engagement of Leading Mining Consultants, Yukon, Canada
Published on 07/07/2026 at 09:05, 4 hours 4 minutes ago HM Exploration Expands Newly Discovered Blind Massive Sulphide Lens at Lewis Pilley's Project
Published on 07/07/2026 at 11:47, 1 hour 21 minutes ago LM PAY S.A. Reports Solid FY 2025 Performance and Positive Q1 2026 Business Momentum - Preliminary Results
Published on 07/07/2026 at 11:25, 1 hour 43 minutes ago thyssenkrupp nucera and Bharat Heavy Electricals Limited Sign Strategic Collaboration to Advance Green Hydrogen Electrolysis in India
Published on 07/07/2026 at 11:23, 1 hour 46 minutes ago AUTODOC intends to launch a senior secured term loan B
Published on 07/07/2026 at 11:00, 2 hours 9 minutes ago GBC AG initiates coverage of MustGrow Biologics Corp. with a BUY rating, 'From mustard seed to scalable biologicals platform'
Published on 07/07/2026 at 10:01, 3 hours 7 minutes ago Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Published on 07/06/2026 at 18:00, 19 hours 9 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 26 juin 2026
Published on 07/06/2026 at 18:00, 19 hours 9 minutes ago Information concerning the total number of voting rights and shares in the share capital as of June 26, 2026
Published on 07/06/2026 at 18:00, 19 hours 9 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 juin 2026
